The new medication offers hope to patients grappling with the early stages of this relentless memory ... drug after ...

University Hospitals Brain Health & Memory Center is now treating patients with KISUNLA™ (donanemab), a Food and Drug ...

This is the second diagnostic drug available for visualising beta amyloid on a PET scan of the brain. In 2012, the FDA approved Amyvid ... such as memory and judgment, that raise the possibility ...

It was one of the most difficult rescue missions of all time, involving as many as 10,000 people, and now we know that rescuers gave the boys a drug ... the brain. Narrator: So while FDA approval ...

The FDA has fast-tracked a drug to treat severe traumatic brain injury from Swedish pharma ... in order to get the product approved and to patients faster. NeuroSTAT works by protecting and ...

So-called deep brain stimulation (DBS) has been approved by the US Food and Drug Administration for treating a range of conditions including Parkinson's disease, epilepsy and obsessive compulsive ...

The newly approved drug works by mimicking two naturally occurring ... feel full longer and also works on hunger centers in the brain to prevent cravings. GIP works in the brain to decrease ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.